COSME-AI4DIAG – “Strategic Cluster Partnership for increased competitiveness of European Medical Diagnostics SMEs through Artificial Intelligence”
The health technologies’ digitalization process pass through a significant riorganisation of the way of understanding the potentialities also for an eventual disease’s prevention, prediction and personalised treatment. AI4DIAg aims at fostering this transition process supporting sme operating in the diagnostic field in the use of big data in order to improve their own technologies and services. The project was born thanks to the strategic cooperation among european clusters with the objective to improve the Artificial Intelligence industrial potential analisation ability.
AI4DIAg has a 24 months duration and a budget of 335.000 Euros and represents a foundamental part in the european strategy to preserve pharmaceutical companies’ competitiveness at a global level.
AI4DIAg focuses on three technology areas: Image Processing, Medical Signal Analytics and Genomics to develop and increase sme’s skills in the use and integration of Artificial Intelligence and Machine Learning algorithms in their solutions both from a technological and regulatory point of view.
AI4DIAg reinforces technology clusters’ role as main actors in european industrial policies and is carried on by EUROBIOMED (FR), TOSCANA LIFE SCIENCES (IT), ARAHEALTH (ES), TALLINN SCIENCE PARK TEHNOPOL (EE), FLANDERSBIO (BE).